Print Page | Contact Us | Sign In | Register
BIO Asia International Conference
Tell a Friend About This EventTell a Friend
BIO Asia International Conference

The BIO Asia International Conference brings together the global biotechnology and pharmaceutical industry to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market.

 Export to Your Calendar 3/19/2018 to 3/20/2018
When: Monday, March 19, 2018
Where: Grand Hyatt Tokyo
6-10-3 Roppongi
Minato-Ku
Tokyo 106-0032
Japan

« Go to Upcoming Event List  

Register Here

The 15th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements.

The conference features private, pre-arranged one-on-one meetings between senior-level executives, using BIO’s proprietary, state-of-the-art computer software. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivaled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time.

Statistics from 2017:

  • More than 370 delegates attended from 27 countries
  •  
  • Over 1,200 BIO One-on-One Partnering™ meetings
  •  
  • More than 230 companies represented
  •  
  • 35 innovative companies from around the world presenting their story 

Why You Should Attend

  • Access to senior-level executives from leading international pharmaceutical & biotechnology companies.

  • Exposure to new and exciting companies ready for partnerships and licensing opportunities in the U.S., Europe and Asia.
  •  
  • Tremendous networking opportunities to meet numerous U.S., European, Japanese and Asian biotech and pharmaceutical companies in one place at one time.
  •  
  • Use of state-of-the-art partnering technology.
  •  
  • Targeted partner selections through proprietary screening process.
  •  
  • Private meetings scheduled by BIO.
  •  
  • Informative plenary sessions.

Who Should Attend

  • Drug development and discovery companies.
  •  
  • Medical technology companies.
  •  
  • Universities and institutes.
  •  
  • Intellectual property and legal organizations.
  •  
  • Investors and financial services providers.
  •  
  • Bio-clusters and incubators.
  •  
  • Government and public support agencies.